MTOR and glioblastoma: Clinically, Rios and colleagues described a case of a glioblastoma patient treated with AMD3100 (plerixafor) and a combination of a mammalian target of rapamycin (mTOR), a Sirtuin-1 (Sirt1), and an EGFRvIII inhibitor after conventional chemo-radiotherapy [161].